Main Article Content
Introduction: Sarcopenia, obesity, and sarcopenic obesity are considered risk factors for the health of the elderly, which may cause or worsen the reduction in functional capacity. Objective: To determine the prevalence of sarcopenia, obesity, and sarcopenic obesity among community-dwelling and institutionalized female elderly in Caxias do Sul, Brazil. Methods: Observational epidemiological study, with cross-sectional design. 423 elderly women (≥60 years old) institutionalized and community-dwellers, participated in the study. Sarcopenia was identified according to the criteria established by the European Working Group on Sarcopenia in Older People (EWGSOP). The gait speed test estimated low skeletal muscle mass (SMM) by bioimpedance, low handgrip strength using a hand dynamometer, and low physical performance. Obesity was defined as Body Mass Index ≥27.0kg/m² and sarcopenic obesity by the simultaneous occurrence of obesity and sarcopenia. The Chi-Square test was performed, with a 5% significance level. Results: The overall prevalence of obesity was 53.9%. Sarcopenia was observed in 16.3% of the total sample, affecting 7.5% of the elderly in the community and 25.1% in institutions (p≤0.0001). Regarding sarcopenic obesity, 0.9% of the community and 3.8% of institutionalized elderly presented the dysfunction. Non-sarcopenic elderly women had a high prevalence of obesity. In the elderly of both groups, sarcopenia was more frequent in those with advanced age. Conclusion: Institutionalized elderly women had a higher prevalence of sarcopenia, emphasizing the importance of paying attention to the health of this population and highlighting the need for preventive measures.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY) that allows others to share and adapt the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
2. World Health Organization (WHO). World report on aging and health. Geneva: WHO, 2015.
3. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31. https://doi.org/10.1093/ageing/afy169
4. World Health Organization (WHO). Obesity and overweight. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
5. Villareal DT, Apovian CM, Kushner RF, Klein S. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, the Obesity Society. Am J Clin Nutr. 2005;82(5):923-34. https://doi.org/10.1093/ajcn/82.5.923
6. Batsis JA, Villareal DT. Sarcopenic obesity in older adults: etiology, epidemiology and treatment strategies. Nat Rev Endocrinol. 2018;14(9):513-37. https://doi.org/10.1038/s41574-018-0062-9
7. Antunes AC, Araujo DA, Verissimo MT, Amaral TF. Sarcopenia and hospitalization costs in older adults: a cross‐sectional study. Nutr Dietetics. 2017;74(1):46-50. https://doi.org/10.1111/1747-0080.12287
8. Araujo MYC, Norberto MCCS, Mantovani AM, Turi-Lynch BC, Santos LL, Ricardo SJ, et al. Obesity increases costs with productivity loss due to disability retirements, independent of physical activity: a cohort study. J Occup Environ Med. 2020;62(5):325-30. https://doi.org/10.1097/JOM.0000000000001808
9. Woo J, Leung J. Sarcopenic obesity revisited: insights from the Mr and Ms os cohort. J Am Med Dir Assoc. 2018;19(8):679-84.e2. https://doi.org/10.1016/j.jamda.2018.03.003
10. Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol. 2000;89(2):465-71. https://doi.org/10.1152/jappl.2000.89.2.465
11. Batsis JA, Mackenzie TA, Barre LK, Lopez-Jimenez F, Bartels SJ. Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III. Eur J Clin Nutr. 2014;68(9):1001-7. https://doi.org/10.1038/ejcn.2014.117
12. Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003;95(5):1851-60. https://doi.org/10.1152/japplphysiol.00246.2003
13. Barbosa-Silva TG, Bielemann RM, Gonzalez MC, Menezes AM. Prevalence of sarcopenia among community-dwelling elderly of a medium-sized South American city: results of the COMO VAI? study. J Cachexia Sarcopenia Muscle. 2016;7(2):136-43. https://doi.org/10.1002/jcsm.12049
14. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412-23. https://doi.org/10.1093/ageing/afq034
15. Kurose S, Nishikawa S, Nagaoka T, Kusaka M, Kawamura J, Nishioka Y, et al. Prevalence and risk factors of sarcopenia in community-dwelling older adults visiting regional medical institutions from the Kadoma Sarcopenia Study. Sci Rep. 2020;10:19129. https://doi.org/10.1038/s41598-020-76185-0
16. Lipschitz DA. Screening for nutritional status in the elderly. Prim Care. 1994;21(1):55-67.
17. Yang L, Yao X, Shen J, Sun G, Sun Q, Tian X, et al. Comparison of revised EWGSOP criteria and four other diagnostic criteria of sarcopenia in Chinese community-dwelling elderly residents. Exp Gerontol. 2020;130:110798. https://doi.org/10.1016/j.exger.2019.110798
18. Chang CS, Chang YF, Liu PY, Wu SJ, Chiu CJ, Chen YC, et al. Interaction of Central Obesity and Sarcopenia on Nutritional Status in the Community-Dwelling Older People. Arch Gerontol Geriatr. 2019;87:104003. https://doi.org/10.1016/j.archger.2019.104003
19. Diz JBM, Leopoldino AAO, Moreira BS, Henschke N, Dias RC, Pereira LSM, et al. Prevalence of sarcopenia in older Brazilians: A systematic review and meta-analysis. Geriatr Gerontol Int. 2017;17(1):5-16. https://doi.org/10.1111/ggi.12720
20. Alexandre TS, Duarte YAO, Santos JLF, Wong R, Lebrão ML. Prevalence and associated factors of sarcopenia among elderly in Brazil: findings from the SABE study. J Nutr Health Aging. 2014;18(3):284-90. https://doi.org/10.1007/s12603-013-0413-0
21. Tagliapietra BL, Vaz TL, Schuch NJ, Margutti KMM. Preditores para diagnóstico de sarcopenia, estado nutricional e atividade física de idosas institucionalizadas e não institucionalizadas. Disciplinarum Sci. 2016;17(1):53-62.
22. Lima LM, Souza RJS, Cunha MRH, Leopoldo AS, Leopoldo APL. Prevalência de sobrepeso e obesidade em idosas do Centro de Convivência para a Terceira Idade de Vitória/ES. Rev Bras Cienc Saude. 2017;21(2):119-26. https://doi.org/10.4034/RBCS.2017.21.02.03
23. Bahat G, Kilic C, Topcu Y, Aydin K, Karan MA. Fat percentage cutoff values to define obesity and prevalence of sarcopenic obesity in community-dwelling older adults in Turkey. Aging Male. 2018;1-7. https://doi.org/10.1080/13685538.2018.1530208
24. Teixeira VBD, Machado CJ, Faria MG, Gonçalves RV. Transição nutricional no Estado de Minas Gerais em 1974 e 2009: um estudo com enfoque na população idosa. Rev Bras Edu Cult. 2018;(17):1-24.
25. Bedogni G, Pietrobelli A, Heymsfield SB, Borghi A, Manzieri AM, Morini P, et al. Is body mass index a measure of adiposity in elderly women? Obes Res. 2001;9(1):17-20. https://doi.org/10.1038/oby.2001.3
26. Zong G, Zhang Z, Yang Q, Wu H, Hu FB, Sun Q. Total and regional adiposity measured by dual-energy X-ray absorptiometry and mortality in NHANES 1999-2006. Obesity (Silver Spring). 2016;24(11):2414-21. https://doi.org/10.1002/oby.21659
27. Benton MJ, Whyte MD, Dval BW. Sarcopenic obesity: strategies for management. Am J Nurs. 2011;111(12):38-46. https://doi.org/10.1097/01.NAJ.0000408184.21770.98
28. Oliveira TM, Roriz AKC, Barreto-Medeiros JM, Ferreira AJF, Ramos L. Sarcopenic obesity in community-dwelling older women, determined by different diagnostic methods. Nutr Hosp. 2019;36(6):1267-72. http://dx.doi.org/10.20960/nh.02593
29. Carmienke S, Freitag MH, Pischon T, Schlattmann P, Fankhaenel T, Goebel H, et al. General and abdominal obesity parameters and their combination in relation to mortality: a systematic review and meta-regression analysis. Eur J Clin Nutr. 2013;67(6):573-85. http://dx.doi.org/10.1038/ejcn.2013.61
30. Crisostomo LAHK. Prevalência e incidência de obesidade sarcopênica em coorte de idosos domiciliados no município de São Paulo [dissertation]. [São Paulo]: Universidade de São Paulo; 2016.
31. Oliveira Neta RS, Souza IFS, Câmara SMA, Souza MC. Sarcopenia, nutritional status, and functionality in elderly women living in the community. Rev Bras Geriatr Gerontol. 2018;21(3):342-51. https://doi.org/10.1590/1981-22562018021.170181
32. Ianiski VB, Schwanke CHA. Obesidade sarcopênica e fatores de risco cardiometabólico em idosos da comunidade [dissertation]. [Porto Alegre]: Pontifícia Universidade Católica do Rio Grande do Sul; 2020.
33. Machado KLLL. Fatores de risco para baixa massa muscular em coorte prospectiva de idosas brasileiras residentes na comunidade: São Paulo Ageing & Health Study (SPAH) [dissertation]. [São Paulo]: Universidade de São Paulo; 2019.
34. Matsushita T, Nishioka S, Taguchi S, Yamanouchi A. Sarcopenia as a predictor of activities of daily living capability in stroke patients undergoing rehabilitation. Geriatr Gerontol Int. 2019;19(11):1124-8. https://doi.org/10.1111/ggi.13780
35. Zhang N, Zhu WL, Liu XH, Chen W, Zhu ML, Kang L, et al. Prevalence and prognostic implications of sarcopenia in older patients with coronary heart disease. J Geriatr Cardiol. 2019;16(10):756-63. https://doi.org/10.11909/j.issn.1671-5411.2019.10.002
36. Cunha BS, Souza CRG, Prudente LOB, Osório NB, Silva Neto LS. Sarcopenia em idosas quilombolas: análise das variáveis antropométricas e de força de preensão manual. Rev Pat Tocantins. 2017;4(3):9-15. https://doi.org/10.20873/uft.2446-6492.2017v4n3p9
37. Lee J. Associations between handgrip strength and disease-specific mortality including cancer, cardiovascular, and respiratory diseases in older adults: a meta-analysis. J Aging Phys Act. 2019;5(1):1-12. https://doi.org/10.1123/japa.2018-0348
38. Gadelha AB, Dutra MT, Oliveira RJ, Safons MP, Lima RM. Associação entre força, sarcopenia e obesidade sarcopénica com o desempenho funcional de idosas. Motri. 2014;10(3):31-9. http://dx.doi.org/10.6063/motricidade.10(3).2775
39. Amigues I, Schott AM, Amine M, Gelas-Dore B, Veerabudun K, Paillaud E, et al. Low skeletal muscle mass and risk of functional decline in elderly community-dwelling women: the prospective EPIDOS study. J Am Med Dir Assoc. 2013;14(5):352-7. https://doi.org/10.1016/j.jamda.2012.12.002
40. Dufour AB, Hannan MT, Murabito JM, Kiel DP, McLean RR. Sarcopenia definitions considering body size and fat mass are associated with mobility limitations: the Framingham Study. J Gerontol A Biol Sci Med Sci. 2013;68(2):168-74. https://doi.org/10.1093/gerona/gls109